54 studies found for:    NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Rank Status Study
21 Recruiting Optimization of NULOJIX® (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Condition: Pancreas and Kidney Transplant
Interventions: Biological: Belatacept;   Drug: methylprednisolone;   Biological: Anti-thymocyte Globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
22 Recruiting Genomics of Kidney Transplantation
Condition: Kidney Transplantation
Intervention:
23 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
24 Recruiting T Cell Effector and Regulatory Mechanisms in Asthma
Conditions: Asthma;   Allergies
Interventions: Biological: Allergen Challenge;   Procedure: PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging)
25 Recruiting Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
Condition: Asthma
Intervention:
26 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
27 Recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
28 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
29 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
30 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:
31 Recruiting Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
Condition: Food Allergy
Interventions: Drug: Egg Oral Immunotherapy;   Drug: Baked Egg
32 Recruiting Imaging of Type 1 Diabetes Progression
Condition: Type 1 Diabetes
Intervention: Drug: ferumoxytol
33 Recruiting Tolerance Following Peanut Oral Immunotherapy
Condition: Peanut Allergy
Interventions: Drug: Peanut Flour;   Drug: Oat Flour
34 Recruiting Validation of Gene Expression Markers of Renal Allograft Functional Decline
Condition: Kidney Transplantation
Intervention:
35 Recruiting Study of the Complications Associated With Certain Stem Cell Transplants
Condition: Stem Cell Transplantation
Intervention:
36 Recruiting Interferon Responses in Eczema Herpeticum (ADEH)
Conditions: Atopic Dermatitis;   Eczema Herpeticum;   Herpes Simplex Infections;   Eczema Vaccinatum
Intervention:
37 Recruiting Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Condition: Cardiac Allograft Vasculopathy
Interventions: Biological: Rituximab induction/conventional immunosuppression (tacrolimus, MMF, and steroid taper);   Drug: Rituximab placebo/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
38 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
39 Recruiting Sustainable East Africa Research in Community Health
Conditions: HIV;   Tuberculosis;   Hypertension;   Diabetes;   Maternal Child Health;   Cost Effectiveness
Intervention: Other: ART access with optimized linkage and retention and streamlined care delivery for all persons with HIV
40 Recruiting Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Condition: Kidney Transplantation
Intervention: Biological: Hematopoietic Stem Cell Transplant/novel platform technology

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-54) Show next page of results
Indicates status has not been verified in more than two years